Africa-Press – Mozambique. The president of the Association of Pharmacists of Mozambique (AFARMO), Lucien Pierre Nkunda Lukusa, told newspaper Domingo that Mozambique has none of the four cough syrups produced by an Indian company and linked to the acute renal failures which caused the death of around 70 children in the Gambia in the last three months.
The four paediatric cough syrups manufactured by Maiden Pharmaceuticals are called Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup.
World Health Organization (WHO) laboratory analysis has identified potentially toxic components in samples of the products.
“The marketing of medicines in Mozambique is well regulated, we have very strong legal mechanisms. The importer must be recognized, that is, carry an authorization for the purpose and the medicine registered in the country,” Nkunda Lukusa explained.
According to Lucien Pierre Nkunda Lukusa, Mozambique does not market any medicine from Maiden Pharmaceuticals.
He added that any medicine which leaves India for Mozambique must have a quality certificate, after undergoing a pre-shipment test.
Lucien Pierre Nkunda Lukusa said that the Mozambican authorities are on alert because there may be people who have recently travelled and may have acquired the syrups in other countries.
For More News And Analysis About Mozambique Follow Africa-Press
